United States · FDA National Drug Code directory
Liothyronine Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59762-1207_4f442ced-f23b-4005-95e2-4ce01636ac19
- Product NDC
- 59762-1207
- Form
- TABLET
- Composition / generic term
- liothyronine sodium
- Labeler
- Mylan Pharmaceuticals Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20190624
- Source listing expiry
- 20271231
Source-listed ingredients
- LIOTHYRONINE SODIUM — 25 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (59762-1207-1) · 59762-1207-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →